Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOLO
4851
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
| $286K | ﹤0.01% |
460,091
+285,195
| +163% | +$165K |
|
4852
Hercules Capital
HTGC
$3.28B
| $285K | ﹤0.01% |
19,263
-123,074
| -86% | -$1.69M |
|
4853
Clearfield
CLFD
$407M
| $285K | ﹤0.01% |
6,019
-295,958
| -98% | -$12.6M |
|
|
PHK
4854
PIMCO High Income Fund
PHK
$852M
| $284K | ﹤0.01% |
56,840
+29,740
| +110% | +$142K |
|
|
BCLI
4855
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $283K | ﹤0.01% |
9,173
+8,425
| +1,126% | +$349K |
|
|
BCIC
4856
BCP Investment Corp
BCIC
$95M
| $283K | ﹤0.01% |
+14,255
| New | +$284K |
|
4857
First United
FUNC
$279M
| $283K | ﹤0.01% |
19,835
+4,447
| +29% | +$65.7K |
|
4858
Tactile Systems Technology
TCMD
$523M
| $283K | ﹤0.01% |
11,345
-206,681
| -95% | -$4.29M |
|
|
ITIC
4859
Investors Title Co
ITIC
$574M
| $283K | ﹤0.01% |
1,935
-88
| -4% | -$12.5K |
|
4860
Champions Oncology
CSBR
$69.7M
| $282K | ﹤0.01% |
44,830
-15,423
| -26% | -$79.6K |
|
4861
Oramed Pharmaceuticals
ORMP
$212M
| $281K | ﹤0.01% |
78,620
-87,150
| -53% | -$279K |
|
4862
Silicon Laboratories
SLAB
$7.31B
| $281K | ﹤0.01% |
1,782
-179,075
| -99% | -$27M |
|
4863
CALL
Cloudflare
NET
$110B
| $281K | ﹤0.01% |
4,300
-500
| -10% | -$29.8K |
|
4864
RBB Bancorp
RBB
$444M
| $281K | ﹤0.01% |
23,497
-31,483
| -57% | -$378K |
|
4865
Universal Logistics Holdings
ULH
$499M
| $281K | ﹤0.01% |
9,737
-83,531
| -90% | -$2.31M |
|
4866
Arena Group
AREN
$44.8M
| $281K | ﹤0.01% |
+61,249
| New | +$244K |
|
4867
Nuvation Bio
NUVB
$2.45B
| $280K | ﹤0.01% |
155,561
-332,728
| -68% | -$566K |
|
4868
PTC Therapeutics
PTCT
$5.99B
| $279K | ﹤0.01% |
+6,861
| New | +$336K |
|
4869
Caleres
CAL
$421M
| $278K | ﹤0.01% |
11,619
-153,989
| -93% | -$3.45M |
|
|
ESPR
4870
CALL
DELISTED
Esperion Therapeutics
ESPR
| $278K | ﹤0.01% |
200,000
-300,000
| -60% | -$419K |
|
4871
Mitek Systems
MITK
$867M
| $278K | ﹤0.01% |
25,609
-33,102
| -56% | -$323K |
|
|
GAU
4872
Galiano Gold
GAU
$630M
| $277K | ﹤0.01% |
469,835
-501,789
| -52% | -$314K |
|
4873
Entrada Therapeutics
TRDA
$283M
| $277K | ﹤0.01% |
18,298
-178,955
| -91% | -$2.47M |
|
4874
CALL
XP
XP
$8.97B
| $277K | ﹤0.01% |
11,800
-1,900
| -14% | -$32.2K |
|
4875
Momentus
MNTS
$93.8M
| $276K | ﹤0.01% |
70
+54
| +338% | +$254K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.